AHFS Drug Information

11th February 2025

AHFS Drug Information

This update contains 6 new monographs and 21 revised monographs.

New monographs: Acoramidis Hydrochloride; Eladocagene Exuparvovec-tneq; Obecabtagene Autoleucel; Revumenib Citrate; Sulopenem etzadroxil and probenecid; Zanidatamab-hrii.

Revised monographs: Alpelisib; Aprocitentan; Aztreonam; Copyright and Notices; Empagliflozin; Ensifentrine; Epcoritamab-bysp; Furosemide; Iptacopan Hydrochloride; Ivacaftor; Ketamine Hydrochloride; Losartan Potassium; Obeticholic Acid; Omalizumab; Osimertinib Mesylate; Respiratory Syncytial Virus Vaccine (mRNA); Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine, Adjuvanted; Risankizumab-rzaa; Ustekinumab; Vericiguat.

14th January 2025

AHFS Drug Information

This update contains 4 new monographs and 13 revised monographs.

New monographs: Foscarbidopa and Foslevodopa; Inavolisib; Marstacimab-hncq;
Zolbetuximab-clzb.

Revised monographs: Aminocaproic Acid; Apalutamide; Apremilast; Cefiderocol; Celecoxib; Coagulation Factor Xa (Recombinant), Inactivated-zhzo (Systemic); Influenza Vaccine Inactivated; Lisinopril; Ponatinib; Ripretinib; Sarilumab; Tenapanor; Tocilizumab.

10th December 2024

AHFS Drug Information

This update contains 8 new monographs and 39 revised monographs.

New monographs: Arimoclomol Citrate; Artesunate; Azithromycin (EENT); Denileukin diftitox-cxdl; Deuruxolitinib Phosphate; Lebrikizumab-lbkz; Levacetylleucine; Xanomeline Tartrate and Trospium Chloride.

Revised monographs: Adagrasib; Adalimumab; Alectinib Hydrochloride; Benralizumab; Casimersen; Danicopan; Deflazacort; Dronabinol; Dupilumab; Edaravone; Eflornithine Hydrochloride; Enfuvirtide; Estrogen-Progestin Combinations; Etrasimod Arginine; Ixazomib Citrate; Ixekizumab; Lanreotide Acetate; Leniolisib Phosphate; Lidocaine Hydrochloride (Systemic); Lomustine; Midazolam, Midazolam Hydrochloride; Mirikizumab-mrkz; Nedosiran Sodium; Ozanimod Hydrochloride; Pirtobrutinib; Pozelimab-bbfg; Repotrectinib; Resmetirom; Riluzole; Sotatercept-csrk; Tepotinib Hydrochloride; Tisotumab vedotin-tftv; Tofersen; Tovorafenib; Tralokinumab-ldrm; Vadadustat; Vasopressin; Vedolizumab; Zanubrutinib.

12th November 2024

AHFS Drug Information

8th October 2024

AHFS Drug Information

This update contains 5 new monographs and 37 revised monographs.

New monographs: Afamitresgene Autoleucel; Crovalimab-akkz; Donanemab-azbt; Ensifentrine; Sofpironium Bromide.

Revised monographs: Armodafinil; Bimekizumab-bkzx; Cipaglucosidase alfa-atga; Cladribine (Immunomodulatory Agent); Clevidipine Butyrate; Desvenlafaxine, Desvenlafaxine Succinate; Dolutegravir Sodium; Dolutegravir Sodium and Rilpivirine Hydrochloride; Dornase Alfa; Efbemalenograstim alfa-vuxw; Emtricitabine and Tenofovir Disoproxil Fumarate; fentaNYL, fentaNYL Citrate; Fingolimod Hydrochloride; Fostemsavir Tromethamine; Heparin Sodium; Iptacopan Hydrochloride; Levomilnacipran Hydrochloride; Monomethyl Fumarate; Natalizumab; Nirogacestat Hydrobromide; Nirsevimab-alip; Oteseconazole; Peginterferon Alfa (Antiviral); Pemigatinib; Pitavastatin Calcium, Pitavastatin Magnesium; Ponesimod; Pralsetinib; Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine (mRNA); Respiratory Syncytial Virus Vaccine, Adjuvanted; Reteplase; Retifanlimab; Rocuronium Bromide; Tacrolimus (Atopic Dermatitis); Tenecteplase; Vasopressin; Vecuronium Bromide.

10th September 2024

AHFS Drug Information

This update contains 2 new monographs and 29 revised monographs.

New monographs: Elafibrinor; Imetelstat Sodium.

Revised monographs: Abatacept; Amifampridine Phosphate; Asciminib Hydrochloride; azaCITIdine; Bosentan; Dalfampridine; Delandistrogene Moxeparvovec-rokl; Deutetrabenazine; Dimethyl Fumarate; Diroximel Fumarate; Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate; Elranatamab-bcmm; Enzalutamide; Fosamprenavir Calcium; L-Glutamine; Lisocabtagene Maraleucel; Momelotinib Dihydrochloride; Morphine Sulfate; Nabilone; Nelfinavir Mesylate; Nevirapine; Niraparib Tosylate; Omacetaxine Mepesuccinate; Omidenepag Isopropyl; Palbociclib; Relugolix; Ritlecitinib Tosylate; Ruxolitinib Phosphate (Topical); Tuberculin Purified Protein Derivative (Interdermal).